Essential Thrombocythaemia — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Essential thrombocythaemia
Persistent thrombocytosis (>450 × 10⁹/L) with JAK2 positivity (~60% of ET), erythromelalgia (pathognomonic for MPN-related thrombocytosis), and characteristic bone marrow (large hyperlobulated megakaryocytes) fulfils WHO 2022 criteria for ET. Risk-stratify using IPSET-Thrombosis score. Treatment: aspirin for all (unless very high platelets >1500 — acquired VWD risk); cytoreduction (hydroxyurea) for high-risk patients (age >60 or prior thrombosis).
Reference: WHO – 2022 – MPN; ELN 2024